Comparison of Focused and Radial Extracorporeal Shock Wave for Carpal Tunnel Syndrome
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03671473 |
|
Recruitment Status :
Withdrawn
(It is difficult to enroll patients)
First Posted : September 14, 2018
Last Update Posted : October 13, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Carpal Tunnel Syndrome | Device: Extracorporeal shock wave | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 0 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Comparison of Focused and Radial Extracorporeal Shock Wave for Carpal Tunnel Syndrome |
| Actual Study Start Date : | January 1, 2019 |
| Actual Primary Completion Date : | December 31, 2020 |
| Actual Study Completion Date : | December 31, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Focused
fESWT (0.05-0.29 mJ/mm2, 2000 shocks, 5 Hz)
|
Device: Extracorporeal shock wave
Shock waves are defined a sequence of acoustic pulse characterized by a high peak pressure (100 MPa), fast pressure rise (< 10 ns) and short duration (10 μs). Different studies and clinical experiments have demonstrated the efficacy of shock waves in the treatment of musculoskeletal system such as chronic tendinopathies or hypertrophic pseudoarthrosis. |
|
Active Comparator: Radial
rESWT (2000shocks, 4 Bar, 5Hz)
|
Device: Extracorporeal shock wave
Shock waves are defined a sequence of acoustic pulse characterized by a high peak pressure (100 MPa), fast pressure rise (< 10 ns) and short duration (10 μs). Different studies and clinical experiments have demonstrated the efficacy of shock waves in the treatment of musculoskeletal system such as chronic tendinopathies or hypertrophic pseudoarthrosis. |
- Change from baseline of Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) at 24th weeks after treatment [ Time Frame: Change of the mean of total SSS and FSS from baseline at 24th weeks after treatment ]Boston carpal tunnel syndrome questionnaire (BCTQ) is a frequently used patient-based questionnaire for measurement of carpal tunnel syndrome which encompasses two components. eleven questions and eight items were evaluated to rate the symptom severity scale (SSS) and functional status scale (FSS), respectively. Each question or item ranges from 1 to 5 with a higher score indicating severer symptom or a higher degree of disability. Total score of SSS ranges from 11-55 and FSS from 8-40. The mean of total SSS and FSS divided with each item score were used for further analysis.
- Visual analogue scale (VAS) [ Time Frame: Pre-treatment, 2nd, 4th, 8th, 12th and 24th weeks after treatment ]Digital pain severity or paresthesia/dysthesia within 1 week prior to evaluation was evaluated using visual analog scale (VAS). Pain score scale ranged from 0 to 10, with 10 indicating the most severe pain.
- Nerve conduction velocity [ Time Frame: Pre-treatment, 2nd, 4th, 8th, 12th and 24th weeks after treatment ]Change from baseline in conduction velocity of median nerve on 2nd, 4th, 8th,12th and 24th weeks after treatment.
- Cross-sectional area (CSA) of the median nerve [ Time Frame: Pre-treatment, 2nd, 4th, 8th, 12th and 24th weeks after treatment ]Change from baseline in cross-sectional area of the median nerve on 2nd, 4th, 8th, 12th and 24th weeks after treatment.
- Nerve conduction amplitude [ Time Frame: Pre-treatment, 2nd, 4th, 8th, 12th and 24th weeks after treatment ]Change from baseline in conduction amplitude of median nerve on 2nd, 4th, 8th,12th and 24th weeks after treatment.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years to 80 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Clinical and electrophysiological diagnosis of CTS
Exclusion Criteria:
- Cervical radiculopathy
- Polyneuropathy
- Brachial plexopathy
- Thoracic outlet syndrome
- Previous wrist surgery or steroid injection for CTS
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03671473
| Taiwan | |
| Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital | |
| Taipei, Neihu District, Taiwan, 886 | |
| Principal Investigator: | Yung-Tsan Wu, MD | Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital |
| Responsible Party: | Yung-Tsan Wu, Principal Investigator, Tri-Service General Hospital |
| ClinicalTrials.gov Identifier: | NCT03671473 |
| Other Study ID Numbers: |
TSGHIRB: 1-107-05-074 |
| First Posted: | September 14, 2018 Key Record Dates |
| Last Update Posted: | October 13, 2021 |
| Last Verified: | October 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Carpal Tunnel Syndrome Extracorporeal shock wave |
|
Carpal Tunnel Syndrome Syndrome Disease Pathologic Processes Median Neuropathy Mononeuropathies Peripheral Nervous System Diseases |
Neuromuscular Diseases Nervous System Diseases Nerve Compression Syndromes Cumulative Trauma Disorders Sprains and Strains Wounds and Injuries |

